Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
about
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disordersDifferent doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaComparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopeniaComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAntifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersAnti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disordersAntibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remissionTrali ou œdème pulmonaire lésionnel aigu post-transfusionnel: à propos d’un cas avec revue de la littératureAnemia and blood transfusions in critically ill patientsTransfusion-related acute lung injury (Trali) in a patient with a single lung transplantTransfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusionAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials.Transfusion-related acute lung injury and potential risk factors among the inpatient US elderly as recorded in Medicare claims data, during 2007 through 2011.Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.Acute lung injury after blood transfusion in mechanically ventilated patients.A case report of transfusion-related acute lung injury during plasma exchange therapy for thrombotic thrombocytopenia purpura.Platelet transfusions for patients with haematological malignancies: who needs them?Approach of using established and new laboratory tests to more comprehensively investigate noninfectious and nonhemolytic transfusion reactions--along with the experience in Japan.Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.The transfusion-related acute lung injury controversy: lessons from heparin-induced thrombocytopenia.The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with HypofibrinogenaemiaTransfusion-related acute lung injury.Postpartum immunologic-mediated pulmonary edema associated with transfusion of blood containing an anti-B-lymphocyte antibody.Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivoMicrocirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study.The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationLong-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patientsA microengineered model of RBC transfusion-induced pulmonary vascular injuryAcute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.TRALI in Perioperative Period-A Case Report.Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).The role of neutrophils in the pathogenesis of transfusion-related acute lung injury.
P2860
Q24186028-2A2EC950-3FAC-442E-A846-F2C6B0AB118AQ24186359-12F8293B-EF1D-4154-A9C9-61E6DA542932Q24186913-863C8D22-55FE-459E-94B4-C94847E55B47Q24187258-EBD446CD-7086-4013-A167-EF62760B9539Q24187460-E2B77F58-29A9-4336-BB4C-4D9ADADF8EDCQ24187751-B3FD3EAF-4E0B-46DB-95CD-9B6C9F569FE3Q24198288-B33E7CA7-02D5-45AD-AEAA-B57E4B80B35BQ24198774-13DFF20C-CA2A-42F5-8227-9D023D00F918Q24198795-98081669-F84C-4FB5-869A-FA6A9171F602Q24198832-88A3CCEE-97F0-4E0B-8FB9-F0DD40C02F42Q24201018-47CDC6A8-E0E9-447C-9280-8E795ADA4F2FQ24201514-6888F097-3C66-47A1-BC81-37141B5D9389Q24539030-961DCA75-7359-43BA-9C32-9D5B51695BC1Q26784366-05A04E11-7B4F-4C79-9E81-DBBFC8802490Q26822895-F5593656-AE3E-408E-8CDD-B8A5BC4C73D2Q28140254-CF3C794E-2021-491E-B027-5A3D454D1476Q28254823-0B492EE3-71FA-425A-9F91-BC49E640F706Q30248355-D383FE70-F637-4C84-8901-30F5FC483F74Q30248755-A5067BCE-5AB3-44EF-B31E-1EA5ABF0F8E0Q30786714-3F21A16C-30D1-4978-992A-8ABA137B810AQ33344069-54A9E442-0329-4B6E-9C0A-8D779E447F49Q33362738-F7F66C86-3D59-4A7F-8DB2-DB4D5D4007CEQ33378563-C46789EE-2283-4D70-83CD-6CF856F011F8Q33395509-DEF5EA54-DD31-4A91-9804-5CB25E97631BQ33408363-5ED001FC-8283-415E-904B-850991F4BB26Q33415057-A58477CE-52D1-4221-B0AF-54C8FE7DD3A2Q33417080-16624C2D-2597-4B50-B7A2-C8E48F0A452FQ33420150-53B07C7B-841A-4E0D-A5B0-2C86070526E0Q33594247-96FCFF8A-A4FA-46FB-8935-D8DB61727793Q33610835-61EC657C-6F2B-468A-A6EB-3EF54B87AF23Q33616926-E93613A1-FC40-408B-AEC2-9867FA5C7BFBQ33697274-D55B2C45-6726-496A-8455-3D3B14967474Q33754405-F57EF42F-C8C7-4469-AA3B-061266EE28E1Q33760834-0D251C98-BC00-4C13-ABF9-B0AB61E92784Q33776826-C4BC7382-1859-44AF-A8C0-90035FF03CE3Q33793940-98E8B8BC-6876-4715-8613-B4DDF6F83750Q33815051-6ADE463B-F14B-4A04-A4EA-959ED41646BEQ33975203-0B583737-3F2B-476A-8D09-31A91B2E825AQ34038651-6AF799F7-FF90-4433-929B-B496B6A6455FQ34118409-7B2A1639-3322-4EF2-B896-5547BFDE6930
P2860
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
@en
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
@nl
type
label
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
@en
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
@nl
prefLabel
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
@en
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
@nl
P1433
P1476
Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.
@en
P2093
P304
P356
10.1046/J.1537-2995.1985.25686071434.X
P577
1985-11-01T00:00:00Z